Cardio Diagnostics Stock (NASDAQ:CDIO)
Previous Close
$4.58
52W Range
$3.22 - $53.10
50D Avg
$4.15
200D Avg
$11.68
Market Cap
$7.63M
Avg Vol (3M)
$64.85K
Beta
2.91
Div Yield
-
CDIO Company Profile
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.